eXoZymes Inc

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
461874109
SEDOL
N/A
CIK
N/A
exozymes.com
LEI:
©
New: Infographics X-Lab
FIGI: BBG01LFVT4P0
EXOZ
eXoZymes Inc
GICS: - · Sektor: EQTY · Sub-Sektor: -
AI
PROFILER
NAME
eXoZymes Inc
ISIN
US4618741098
TICKER
EXOZ
MIC
XNAS
REUTERS
EXOZ.OQ
BLOOMBERG
EXOZ US
F&G: 59
6.405,11 S&P · 16,78 Vola-Index · 116.789,81 BTC · 1,16419 EURUSD
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von ACCESS Newswire bereitgestellt.
Do., 07.08.2025       eXoZymes
US4618741098

LOS ANGELES, CA / ACCESS Newswire / August 7, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar on Tuesday, August 12, 2025 at 5:00 PM Eastern Time to discuss its result...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Di., 29.07.2025       eXoZymes
US4618741098

Using eXoZymes' AI-driven exozymes platform, NCTx has demonstrated lab scale validation with 4 grams of NCT produced at a 96% yield and with a purity higher than 99%.NCT project went from concept to gram scale production in 5 months and at a fraction of normal SynBio R&D cost.N-trans-caffeoyltyramine (NCT) is a natural product compound attracti...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Di., 22.07.2025       eXoZymes
US4618741098

N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.Using eXoZymes' AI-driven platform, a new and proprietary approach to biomanufacturing of NCT - with all the scale-up advantages of ...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Do., 26.06.2025       eXoZymes
US4618741098

MONROVIA, CA / ACCESS Newswire / June 26, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its role in the Meta-PURE initiative, a $9.2 million USD National Science Foundation (NSF) ...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Fr., 16.05.2025       eXoZymes
US4618741098

MONROVIA, CALIFORNIA / ACCESS Newswire / May 16, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - was featured on the latest episode of the Grow Everything podcast, revealing how the company's...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Mo., 12.05.2025       eXoZymes
US4618741098

Management to host earnings call at 5:00PM Eastern Time, today. MONROVIA, CA / ACCESS Newswire / May 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential nutraceuticals, medicines, biofuels, and other valuable chemicals - provides an update ...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Mi., 07.05.2025       eXoZymes
US4618741098

MONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar on Monday, May 12, 2025 at 5:00 PM Eastern Time to discuss its results for the first q...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
Di., 06.05.2025       eXoZymes
US4618741098

N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.eXoZymes used its AI-driven development platform to progress from idea to purpose-built subsidiary in less than 3 ...
Read More
eXoZymes
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S